Stanford University
Showing 601-610 of 752 Results
-
Alison Hu, PhD, ABPP
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
BioDr. Hu is a Clinical Associate Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine and a board-certified counseling psychologist specializing in psycho-oncology and the psychological care of individuals with complex medical conditions.
Dr. Hu joined the Stanford faculty in 2026 as a member of the Division of Medical Psychiatry and Psychosocial Oncology Program. At the Stanford Cancer Center, she provides psychological assessment and treatment to patients navigating cancer diagnosis, treatment, and advanced illness. She also works in consultation-liaison settings, collaborating with multidisciplinary medical teams to address the psychological and behavioral health needs of patients with acute and complex medical conditions.
Dr. Hu earned her PhD in Counseling Psychology from the University of Minnesota and completed APA-accredited predoctoral internship and postdoctoral fellowship at the Bedford VA Healthcare System. She is board certified in Counseling Psychology by the American Board of Professional Psychology and was selected as an American Psychosocial Oncology Society Health Equity Scholar for 2024–2025.
Her clinical interests include psycho-oncology, health psychology, perinatal mental health, culturally responsive care, and health equity. -
Jiaqi Hu
Postdoctoral Scholar, Cardiovascular Medicine
BioJiaqi Hu is a Postdoctoral Scholar at Stanford University, supervised by Drs. Tim Assimes and Shoa Clarke. She received her PhD in Chronic Disease Epidemiology from the Yale School of Public Health in 2026 and her Bachelor of Arts degree from Peking University in 2021. Her research focuses on identifying genetic variants underlying complex diseases, applying polygenic scores for disease risk prediction and subtype identification, and integrating genetic, environmental, and clinical data to improve individual-level risk stratification.
